Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about MRK

Recent news which mentions MRK

< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Is Gilead Sciences Stock a Buy Now?
Tickers GILD MRK NRXP PFE
Tags Recent Press Releases Market News MRK
From Motley Fool
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
Tickers ACAD APTX AZN BLU
Tags GSK Biotech Benzinga
From Benzinga
Merck Stops Enrollment In Two Islatravir Trials For Prevention Of HIV Infection
Tickers MRK
Tags Benzinga Biotech HIV treatment
From Benzinga
3 Dow Stocks Begging to Be Bought in December
Tickers CRM DJI MRK PFE
Tags Market News CRM PFE
From Motley Fool
Why Vaccine Stocks Like BioNTech and Novavax Are Crashing Today
Tickers ABUS BNTX MRK MRNA
Tags PFE VBIV ABUS
From Motley Fool
Canada, Merck Ink Supply Pact For 1M Doses Of Molnupiravir For COVID-19
Tickers MRK
Tags COVID/19 Coronavirus News General
From Benzinga
Merck's Keytruda Wins Eighth FDA Approval Of 2021, This Time For Adjuvant, Pediatric Melanoma Settings
Tickers MRK
Tags Benzinga Biotech FDA
From Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
Tickers ABBV ADCT AGIO ALNY
Tags Penny Stocks PFE General
From Benzinga
7 Stocks to Buy to Give Your Portfolio a Booster Shot
Tickers ABT COST DIS DUK
Tags DIS HD NYSE:ABT,NYSE:MRK,NYSE:HD,NASDAQ:COST,NYSE:DUK,NYSE:DIS,NASDAQ:MRNA
From InvestorPlace
Here's Why Merck Lost Nearly $40 Billion in Value During November
Tickers MRK PFE
Tags PFE MRK Market News
From Motley Fool
Will Adagio's COVID Antibody Therapy Be Too Late to the Party?
Tickers ADGI MRK PFE
Tags Market News Recent Press Releases ADGI
From Motley Fool
Here's Why The New Coronavirus Variant Won't Harm Pfizer's Stock
Tickers BNTX MRK MRNA PFE
Tags PFE MRK BNTX
From Motley Fool
Bristol Myers - Merck's Thalassemia Candidate Under FDA Priority Review
Tickers BMY MRK
Tags Biotech FDA beta thalassemia
From Benzinga
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
Tickers BGNE BMY ESPR IBB
Tags BMY General News
From Benzinga
3 Stocks to Buy for the New COVID Variant
Tickers MRK MRNA NVAX PFE
Tags MRNA Recent Press Releases NVAX
From Motley Fool
Regeneron: Surfing on Covid, With More Under the Surface
Tickers MRK REGN SNY VTRS
Tags VTRS Market News REGN
From InvestorPlace
Is High Pressure Good for Drug Development?
Tickers AZN MRK PBIO PFE
Tags Biotech Benzinga Health Care
From Benzinga
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
Tickers ABBV AMGN AQST ARGX
Tags EGRX MRK ZLAB
From Benzinga
Vir Biotech - GSK's COVID-19 Antibody Shows Preclinical Activity Against Omicron Variant
Tickers GSK MRK VIR
Tags Benzinga Biotech GSK
From Benzinga
2 Biotech Stocks A Congressman Is Betting On With Omicron Variant Emerging
Tickers ABBV MRK XOM
Tags Benzinga Politics Covid/19
From Benzinga
Market Rollercoaster Continues in Wake of Powell's Comments
Tickers AAPL CCL CRM EXPE
Tags EXPE Health Care CRM
From Benzinga
2 Ridiculously Cheap Dividend Stocks To Buy for 2022
Tickers ABBV AMGN DIS MRK
Tags ABBV Market News AMGN
From Motley Fool
U.S. to tighten testing requirements for travelers in light of omicron variant, and analysts expected limited authorization of Merck antiviral
Tickers BNTX MRK PFE
Tags BNTX PFE MRK
From MarketWatch
After high hopes for Merck’s COVID-19 pill, Wall Street now expects a ‘tepid’ authorization
Tickers MRK PFE SPX
Tags MRK PFE SPX
From MarketWatch
Merck's Pneumococcal 15-valent Conjugate Vaccine Under Priority FDA Review For Use In Kids
Tickers MRK
Tags News General Health Care
From Benzinga
The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case
Tickers ADTX ATNF BIIB BTAI
Tags Offerings SABS ATNF
From Benzinga
AdComm Narrowly Backs Merck's COVID-19 Pill, Despite Efficacy Questions
Tickers MRK PFE
Tags General PFE News
From Benzinga
FDA advisers to vote Tuesday on Merck’s COVID-19 pill even as interest has waned
Tickers GILD GSK LLY MRK
Tags PFE LLY GSK
From MarketWatch
WHO urges calm approach to omicron variant of COVID, warns travel restrictions may undermine surveillance and tracking
Tickers LLY MRK MRNA REGN
Tags MRNA LLY REGN
From MarketWatch
The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout
Tickers ADAG AZN BYSI CPIX
Tags Penny Stocks ADAG MOLN
From Benzinga
< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.